These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4393962)

  • 1. Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation.
    Strobel HW; Lu AY; Heidema J; Coon MJ
    J Biol Chem; 1970 Sep; 245(18):4851-4. PubMed ID: 4393962
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional components and mechanism of action of the resolved liver microsomal enzyme system catalyzing fatty acid, hydrocarbon and drug hydroxylation.
    Coon MJ; Strobel HW; Autor AP; Heidema J; Duppel W
    Biochem Soc Symp; 1972; 34():45-54. PubMed ID: 4144195
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of a solubilized form of the cytochrome P-450-containing mixed-function oxidase of liver microsomes.
    Lu AY; Strobel HW; Coon MJ
    Mol Pharmacol; 1970 May; 6(3):213-20. PubMed ID: 4315336
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects on the hydroxylation of drugs, steroid hormones and fatty acids (omega-oxidation) in rat liver microsomes.
    Orrenius S
    Hoppe Seylers Z Physiol Chem; 1968 Nov; 349(11):1619-21. PubMed ID: 4393649
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation.
    Lu AY; Strobel HW; Coon MJ
    Biochem Biophys Res Commun; 1969 Aug; 36(4):545-51. PubMed ID: 4390187
    [No Abstract]   [Full Text] [Related]  

  • 6. On the fatty acid and hydrocarbon hydroxylation in rat liver microsomes.
    Das ML; Orrenius S; Ernster L
    Eur J Biochem; 1968 May; 4(4):519-23. PubMed ID: 4385528
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional components of the liver microsomal enzyme system catalysing fatty acid, hydrocarbon and drug hydroxylation.
    Coon MJ; Strobel HW; Autor AP; Heidema J; Duppel W
    Biochem J; 1971 Nov; 125(2):2P-3P. PubMed ID: 5144730
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative drug metabolism in human liver microsomes.
    Nelson EB; Raj PP; Belfi KJ; Masters BS
    J Pharmacol Exp Ther; 1971 Sep; 178(3):580-8. PubMed ID: 4398379
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of phospholipid in the reconstituted liver microsomal mixed function oxidase system containing cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Autor AP; Kaschnitz RM; Heidema JK; Van der Hoeven TA; Duppel W; Coon MJ
    Drug Metab Dispos; 1973; 1(1):156-61. PubMed ID: 4149377
    [No Abstract]   [Full Text] [Related]  

  • 12. On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain.
    Franklin MR; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):318-29. PubMed ID: 4397835
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of radioactive- -aminolevulinic acid into microsomal cytochrome P 450 : selective breakdown of the hemoprotein by allylisopropylacetamide and carbon tetrachloride.
    Levin W; Jacobson M; Kuntzman R
    Arch Biochem Biophys; 1972 Jan; 148(1):262-9. PubMed ID: 4400522
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes.
    Lu AY; Coon MJ
    J Biol Chem; 1968 Mar; 243(6):1331-2. PubMed ID: 4385007
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatty acid inducible cy tochrome P-454 of rat kidney cortex microsomes.
    Jakobsson S; Thor H; Orrenius S
    Biochem Biophys Res Commun; 1970; 39(6):1073-80. PubMed ID: 4397847
    [No Abstract]   [Full Text] [Related]  

  • 17. Omega- and (omega - 1)-oxidation of fatty acids by rat liver microsomes.
    Björkhem I; Danielsson H
    Eur J Biochem; 1970 Dec; 17(3):450-9. PubMed ID: 4395440
    [No Abstract]   [Full Text] [Related]  

  • 18. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of substrates of mixed function oxidase on ethanol oxidation in rat liver microsomes.
    Hildebrandt AG; Speck M; Roots I
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):271-82. PubMed ID: 4151424
    [No Abstract]   [Full Text] [Related]  

  • 20. Microsomal hydroxylation of decane.
    Ichihara K; Kusunose E; Kusunose M
    Biochim Biophys Acta; 1969 Jun; 176(4):713-9. PubMed ID: 4389623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.